Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tamoxifen | 2 | 2014 | 168 | 0.850 |
Why?
|
| Streptococcus pneumoniae | 2 | 2013 | 49 | 0.780 |
Why?
|
| Transformation, Genetic | 1 | 2013 | 41 | 0.450 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 198 | 0.420 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 156 | 0.410 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2399 | 0.360 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 612 | 0.330 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 112 | 0.330 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 441 | 0.330 |
Why?
|
| Precision Medicine | 1 | 2013 | 407 | 0.320 |
Why?
|
| Gene Deletion | 1 | 2009 | 342 | 0.310 |
Why?
|
| Retinoblastoma Protein | 3 | 2003 | 67 | 0.250 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 2980 | 0.220 |
Why?
|
| Neoplasms | 2 | 2019 | 3012 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 2406 | 0.190 |
Why?
|
| Cell Cycle Proteins | 1 | 2003 | 399 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2003 | 1649 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 1240 | 0.150 |
Why?
|
| Pain Measurement | 1 | 2019 | 329 | 0.150 |
Why?
|
| Base Sequence | 2 | 2013 | 2331 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2543 | 0.150 |
Why?
|
| Pain | 1 | 2019 | 401 | 0.140 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2014 | 5 | 0.120 |
Why?
|
| HapMap Project | 1 | 2014 | 47 | 0.120 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 56 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 269 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 78 | 0.110 |
Why?
|
| Mercaptopurine | 1 | 2013 | 53 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2013 | 65 | 0.110 |
Why?
|
| Capecitabine | 1 | 2013 | 98 | 0.110 |
Why?
|
| DNA Primers | 1 | 2013 | 543 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 247 | 0.100 |
Why?
|
| Cyclins | 2 | 2002 | 83 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2013 | 107 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 147 | 0.100 |
Why?
|
| Deoxycytidine | 1 | 2013 | 238 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2013 | 192 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 796 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2013 | 559 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 559 | 0.090 |
Why?
|
| Kinetics | 1 | 2013 | 1530 | 0.090 |
Why?
|
| Fucose | 1 | 2009 | 13 | 0.090 |
Why?
|
| Integrases | 1 | 2009 | 60 | 0.090 |
Why?
|
| Genotype | 1 | 2014 | 1867 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2014 | 551 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 353 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 647 | 0.080 |
Why?
|
| Mutation | 3 | 2013 | 4100 | 0.080 |
Why?
|
| Genetic Markers | 1 | 2009 | 478 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 1312 | 0.080 |
Why?
|
| Drosophila | 2 | 2003 | 511 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 956 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2014 | 2009 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2002 | 659 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1142 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 441 | 0.070 |
Why?
|
| Drosophila Proteins | 2 | 2002 | 498 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2013 | 1369 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 1662 | 0.060 |
Why?
|
| Eye | 2 | 2002 | 111 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3029 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2009 | 942 | 0.060 |
Why?
|
| E2F Transcription Factors | 1 | 2003 | 19 | 0.060 |
Why?
|
| Genes, Lethal | 1 | 2003 | 53 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2003 | 140 | 0.060 |
Why?
|
| Fertility | 1 | 2003 | 116 | 0.050 |
Why?
|
| Cyclin E | 1 | 2002 | 28 | 0.050 |
Why?
|
| Female | 3 | 2019 | 45769 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 43 | 0.050 |
Why?
|
| Humans | 4 | 2019 | 88635 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2002 | 508 | 0.040 |
Why?
|
| Outpatients | 1 | 2019 | 98 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 661 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 605 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1694 | 0.030 |
Why?
|
| Cyclin D | 2 | 2002 | 14 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2595 | 0.020 |
Why?
|
| Animals | 3 | 2003 | 27235 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 57 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 63 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2002 | 30 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2002 | 88 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 18939 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2002 | 100 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 289 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 696 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 25710 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1129 | 0.010 |
Why?
|
| Male | 1 | 2019 | 42021 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1214 | 0.010 |
Why?
|